ResMed Unveils 2030 Strategy to Drive Growth, Profitability, and ...
Sep 30, 2024 · Grow and differentiate ResMed’s unmatched core sleep apnea franchise, led by demand generation and demand capture: The 2030 Strategy is underpinned by a focus on …
ResMed Adopts New Operating Model to Accelerate Long-term …
SAN DIEGO, November 9, 2023 – ResMed (NYSE: RMD, ASX: RMD) today announced a new operating model to accelerate long-term growth. The new operating model introduces …
News | Resmed Inc - ResMed Newsroom – ResMed news and …
Sep 10, 2024 · [email protected] 1.858.289.7272. Investor Contact. [email protected] 1.858.836.5000. Newsroom Alerts. To opt-in for email alerts, …
ResMed Inc. (RMD) Latest Stock News & Headlines - Yahoo …
Get the latest ResMed Inc. (RMD) stock news and headlines to help you in your trading and investing decisions.
UPDATE -- ResMed Unveils New Collection of Digital and …
Sep 30, 2024 · ResMed’s new AI-enabled health concierge, Dawn, is changing how people learn about sleep apnea. Dawn provides instant, 24/7 access to many answers about sleep health, …
US FDA Identifies Recall of ResMed's Respiratory Devices as Most …
Jan 11, 2024 · ResMed was recalling some models of its continuous positive airway pressure (CPAP) masks, AirFit and AirTouch, due to possible magnetic interference with certain …
ResMed Unveils 2030 Strategy to Drive Growth, Profitability, and ...
Sep 30, 2024 · NEW YORK and SAN DIEGO, Sept. 30, 2024 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today unveiled its 2030 Strategy to drive growth, profitability, and …
ResMed Inc. Announces Results for the Fourth Quarter of Fiscal …
Aug 1, 2024 · ResMed will discuss its fourth quarter fiscal year 2024 results on its webcast at 1:30 p.m. U.S. Pacific Time today. The live webcast of the call can be accessed on ResMed’s …
ResMed Inc. Announces Results for the Second Quarter of Fiscal …
SAN DIEGO, Jan. 26, 2023 (GLOBE NEWSWIRE) -- ResMed Inc. (NYSE: RMD, ASX: RMD) today announced results for its quarter ended December 31, 2022. Second Quarter 2023 …
Resmed Stock Poised for Growth: Buy Rating Affirmed Amid …
Apr 17, 2024 · In a report released today, Lyanne Harrison from Bank of America Securities reiterated a Buy rating on Resmed (RMD – Research Report), with a price target of $220.00. …